Related references
Note: Only part of the references are listed.The role of vascular endothelial growth factor and matrix metalloproteinases in canine lymphoma: in vivo and in vitro study
Arianna Arico et al.
BMC VETERINARY RESEARCH (2013)
Understanding high grade glioma: Molecular mechanism, therapy and comprehensive management
Yongzhi Wang et al.
CANCER LETTERS (2013)
The role of ubiquitin-proteasome system in glioma survival and growth
Panagiotis J. Vlachostergios et al.
GROWTH FACTORS (2013)
Clinical and molecular models of Glioblastoma multiforme survival
Stephen R. Piccolo et al.
INTERNATIONAL JOURNAL OF DATA MINING AND BIOINFORMATICS (2013)
Immunotherapy targeting glioma stem cells - insights and perspectives
Zhenhua Li et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Therapeutic targeting of VEGF in the treatment of glioblastoma
Lizbeth Robles Irizarry et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Analysis of VEGF, Flt-1, Flk-1, nestin and MMP-9 in relation to astrocytoma pathogenesis and progression.
A. Hlobilkova et al.
NEOPLASMA (2009)
The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression
Michele C. Madigan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression
Marianela Candolfi et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
CG Willett et al.
NATURE MEDICINE (2004)
Hypoxia-inducible factor 1α/vascular endothelial growth factor axis in astrocytomas.: Associations with microvessel morphometry, proliferation and prognosis
P Korkolopoulou et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2004)
Vascular endothelial growth factor as a target for anticancer therapy
N Ferrara
ONCOLOGIST (2004)
Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas
IH Chaudhry et al.
HISTOPATHOLOGY (2001)
Angiogenesis in malignant primary and metastatic brain tumors
JC Reijneveld et al.
JOURNAL OF NEUROLOGY (2000)